CHMA Chiasma, Inc.

1.45
+0.00  (0%)
Previous Close 1.45
Open 1.50
Price To book 0.44
Market Cap 35.32M
Shares 24,359,000
Volume 25,438
Short Ratio 23.46
Av. Daily Volume 49,788

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL April 15 2016
Mycapssa
Acromegaly
Phase 3 continues to enroll as of May 2017. Additional Phase 3 trial will be required for NDA submission.
Mycapssa - MPOWERED
Maintenance treatment of adult acromegaly